AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration that avoided its threats of steep tariffs.
AstraZeneca looks poised to announce a deal with U.S. President Donald Trump that's focused on lowering drug prices, in a move that would see the British drugmaker follow in the footsteps of Pfizer.
Trump announces drug-price deal with AstraZeneca The Washington PostAstraZeneca makes deal with White House to lower drug prices NPRTrump reveals prescription drug deal with pharmaceutical giant AstraZeneca Al JazeeraAstraZeneca makes deal with Trump to lower drug prices and avoid tariffs The Guardian
